Instinct Bio Technical Co. Holdings Inc.（BIOT）股價、財務與研究

盤中時間採用ET。市場資料可能有所延遲。

公司概況

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

產業: Household & Personal Products
部門: Consumer Defensive
總部: US
執行長: Tomoki Nagano
上市以來: 2026年7月24日
僱員: 2

市場位置

日內區間

目前US$0.3792

US$0.3651US$0.3896

52週區間

目前US$0.3792

US$0.33US$50.00

開盤價: US$0.379
前收盤價: US$0.389
成交量: 12.58萬; 0.18× 平均值
平均成交量: 70.42萬; 日均成交量
市值: 163.18萬 USD
貝塔: -0.54; 市場參考 1
50天平均值: US$0.4022; 低於平均水平-5.72%
200天平均值: US$0.7407; 低於平均水平-48.81%

財務數據

財務快照

估值與收益率

本益比（TTM）: -0.9×
股價淨值比（TTM）: -401,255.09×
股價營收比（TTM）: 0×
股息率: 0.00%

獲利能力和效率

毛利率: 0.00%
營業利益率: 0.00%
淨利潤率: 0.00%

財務健康

負債權益比: 0×

BIOT 訊息

globenewswire.com2026年9月4日

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.

閱讀原始碼

globenewswire.com2026年8月10日

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

NEW YORK and TOKYO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced a cooperation agreement with PT PARVA CANDELA ("PARVA"),…

閱讀原始碼

globenewswire.com2026年7月29日

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic…

閱讀原始碼

globenewswire.com2026年7月29日

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” Building a Recurring-Revenue Platform

閱讀原始碼

globenewswire.com2026年7月28日

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

Transformative funding agreement equips Instinct Bio with discretionary capital to scale its longevity-focused ecosystem and capture market opportunities. Transformative funding agreement equips Instinct Bio with…

閱讀原始碼

BIOT同業公司

WMT

Walmart Inc.

US$111.35

+0.71%

COST

Costco Wholesale Corporation

US$946.92

-0.11%

PEP

PepsiCo, Inc.

US$125.97

-1.85%

MNST

Monster Beverage Corporation

US$43.64

-0.02%

MDLZ

Mondelez International, Inc.

US$60.41

-0.43%

CCEP

Coca-Cola Europacific Partners PLC

US$104.25

+0.59%

Instinct Bio Technical Co. Holdings Inc.

公司概況

Instinct Bio Technical Co. Holdings Inc.

公司概況

市場位置

財務數據

財務快照

估值與收益率

獲利能力和效率

財務健康

BIOT 訊息

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT同業公司

繼續GoAI的研究

公司概況

市場位置

公司概況

公司概況

市場位置

公司概況

市場位置

財務數據

財務快照

估值與收益率

獲利能力和效率

財務健康

BIOT 訊息

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT同業公司

繼續GoAI的研究

Instinct Bio Technical Co. Holdings Inc.

BIOT公司概覽

公司概況

Instinct Bio Technical Co. Holdings Inc.

BIOT公司概覽

公司概況

市場位置

財務數據

財務快照

估值與收益率

獲利能力和效率

財務健康

BIOT 訊息

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT同業公司

繼續GoAI的研究

BIOT公司概覽

公司概況

市場位置

BIOT公司概覽

公司概況

BIOT公司概覽

公司概況

市場位置

BIOT公司概覽

公司概況

市場位置

財務數據

財務快照

估值與收益率

獲利能力和效率

財務健康

BIOT 訊息

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT同業公司

繼續GoAI的研究